AZN - AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
Recently reported position changes by institutional investors
Recent trades by U.S. Senators
Date |
Senator |
Type |
3/11/2019 |
Capito, Shelley Moore |
Sale: Stock |
9/8/2017 |
Capito, Shelley Moore |
Purchase: Stock |
Recent trades by U.S. Representatives
Date |
Rep. |
Type |
12/1/2021 |
Alan S. Lowenthal |
Sale |
7/21/2021 |
Dean Phillips |
Exchange |
4/9/2021 |
Sara Jacobs |
Sale |
2/22/2021 |
Alan S. Lowenthal |
Purchase |
2/22/2021 |
Alan S. Lowenthal |
Purchase |
2/22/2021 |
Alan S. Lowenthal |
Purchase |
12/1/2020 |
Greg Gianforte |
Purchase |
2/24/2020 |
Thomas Suozzi |
Sale |
1/15/2020 |
John Rutherford |
Sale |
1/7/2020 |
Thomas Suozzi |
Purchase |
5/28/2019 |
Mikie Sherrill |
Sale |
5/28/2019 |
Mikie Sherrill |
Sale |
5/28/2019 |
Mikie Sherrill |
Sale |
1/14/2019 |
Nicholas Van Taylor |
Sale |
1/7/2019 |
Nicholas Van Taylor |
Sale |
7/11/2017 |
John Rutherford |
Purchase |
Quarterly net insider trading by a company's directors and management
No data for this ticker
Flights by private jets registered to AZN
No data for this ticker
Federal grants, loans, and purchases. Click on a date for more info.
No data for this ticker